The US Food and Drug Administration (FDA) has approved bluebird bio's (BLUE.O) gene therapy for the treatment of a rare neurological disorder, the company said
The US Food and Drug Administration has approved bluebird bio's gene therapy for the treatment of a rare neurological disorder, the company said late on Fr..
The U.S. Food and Drug Administration has approved bluebird bio's gene therapy for the treatment of a rare neurological disorder, the company said lat.
The U.S. Food and Drug Administration has approved bluebird bio's gene therapy for the treatment of a rare neurological disorder, the company said lat.